|
CTNNB1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.441090E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.088400E-01 |
| Normal-vs-Stage2 |
9.735600E-03 |
| Normal-vs-Stage3 |
1.97709999483209E-08 |
| Normal-vs-Stage4 |
8.77269999977059E-08 |
| Stage1-vs-Stage2 |
2.994300E-02 |
| Stage1-vs-Stage3 |
3.38480000028341E-07 |
| Stage1-vs-Stage4 |
7.16359999985983E-07 |
| Stage2-vs-Stage3 |
2.276400E-01 |
| Stage2-vs-Stage4 |
1.287000E-01 |
| Stage3-vs-Stage4 |
5.723800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.040810E-04 |
| Normal-vs-AfricanAmerican |
2.536400E-01 |
| Normal-vs-Asian |
5.769200E-01 |
| Caucasian-vs-AfricanAmerican |
6.155600E-01 |
| Caucasian-vs-Asian |
8.057000E-01 |
| AfricanAmerican-vs-Asian |
9.983800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.85670999999221E-05 |
| Normal-vs-Female |
8.965800E-02 |
| Male-vs-Female |
4.725800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.767000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.620200E-02 |
| Normal-vs-Age(61-80Yrs) |
7.9019000000069E-05 |
| Normal-vs-Age(81-100Yrs) |
8.369500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.697400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.980200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.464200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.603200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.690000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.191400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.618030E-01 |
| Normal-vs-Grade 2 |
9.232400E-01 |
| Normal-vs-Grade 3 |
1.54250001660472E-09 |
| Normal-vs-Grade 4 |
2.30119999722334E-08 |
| Grade 1-vs-Grade 2 |
1.067440E-01 |
| Grade 1-vs-Grade 3 |
1.069510E-02 |
| Grade 1-vs-Grade 4 |
5.51759999999346E-05 |
| Grade 2-vs-Grade 3 |
2.21020000079619E-08 |
| Grade 2-vs-Grade 4 |
3.10470000042251E-07 |
| Grade 3-vs-Grade 4 |
8.218000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.217800E-01 |
| Normal-vs-ccB subtype |
1.52636999999345E-05 |
| ccA subtype-vs-ccB subtype |
3.72100000000097E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.988000E-04 |
| Normal-vs-N1 |
1.415080E-03 |
| N0-vs-N1 |
4.967700E-02 |
|
|
